LETTER
Synthesis of 3-Aroyl-5-hydroxyflavones
1899
(5) Quintin, J.; Roullier, C.; Thoret, S.; Lewin, G. Tetrahedron
2006, 62, 4038.
(6) (a) Fernandes, E.; Carvalho, F.; Silva, A. M. S.; Santos, C.
M. M.; Pinto, D. C. G. A.; Cavaleiro, J. A. S.; Bastos, M. L.
J. Enzym. Inhib. Med. Chem. 2002, 17, 1756.
3¢), 152.3 (C-4¢), 156.3 (C-9), 160.7 (C-5), 164.3 (C-2),
183.4 (C-4) ppm. MS (EI): m/z (%) = 450 (8) [M+]. HRMS
(EI): m/z calcd for C29H22O5: 450.1467; found: 450.1472.
(12) (a) Gaydou, E. M.; Bianchini, J.-P. Bull. Soc. Chim. Fr.
1978, 2, 43. (b) Santos, C. M. M.; Silva, A. M. S.; Cavaleiro,
J. A. S. Eur. J. Org. Chem. 2003, 4575.
(b) Fernandes, E.; Carvalho, M.; Carvalho, F.; Silva, A. M.
S.; Santos, C. M. M.; Pinto, D. C. G. A.; Cavaleiro, J. A. S.;
Bastos, M. L. Arch. Toxicol. 2003, 77, 500. (c) Filipe, P.;
Silva, A. M. S.; Morlière, P.; Brito, C. M.; Patterson, L. K.;
Hug, G. L.; Silva, J. N.; Cavaleiro, J. A. S.; Mazière, J.-C.;
Freitas, J. P.; Santus, R. Biochem. Pharmacol. 2004, 67,
2207.
(13) Looker, J. H.; Edman, J. R.; Dappen, I. J. Heterocycl. Chem.
1964, 1, 141.
(14) See, for example: (a) Brito, C. M.; Pinto, D. C. G. A.; Silva,
A. M. S.; Silva, A. M. G.; Tomé, A. C.; Cavaleiro, J. A. S.
Eur. J. Org. Chem. 2006, 2558. (b) Silva, V. L. M.; Silva,
A. M. S.; Pinto, D. C. G. A.; Cavaleiro, J. A. S. Synlett 2006,
1369.
(7) Pinto, D. C. G. A.; Silva, A. M. S.; Almeida, L. M. P. M.;
Cavaleiro, J. A. S.; Elguero, J. Eur. J. Org. Chem. 2002,
3807; and references cited therein.
(8) Pinto, D. C. G. A.; Silva, A. M. S.; Cavaleiro, J. A. S. New
J. Chem. 2000, 24, 85.
(15) Optimised Experimental Procedure
A mixture of the appropriate 2¢,6¢-diaroyloxyacetophenone
3a–c and 4a–c (0.5 mmol) with anhyd K2CO3 (152 mg, 1.1
mmol) in anhyd pyridine (6 mL), was poured in a two-
necked glassware apparatus equipped with a magnetic
stirring bar, fibre-optic temperature control and reflux
condenser, and was then irradiated in an Ethos SYNTH
microwave (Milestone Inc.) at constant power of 400 W for
10 min. After that period the reaction mixture was poured
into a mixture of ice and water and the pH was adjusted to 3–
4 with diluted HCl. The obtained solid was filtered off and
recrystallised from EtOH to provide the 3-aroyl-5-
hydroxyflavones 5a–c and 6a–c; in several cases a
purification by column chromatography was necessary,
using CHCl3 as eluent (5a, 70%; 5b, 69%; 5c, 72%; 6a, 72%;
6b, 68%; 6c, 73%).
(9) Optimised Experimental Procedure
A mixture of the 2¢,6¢-dihydroxyacetophenone (2a, 0.92 g,
6.05 mmol), the appropriate benzoic acid (13.31 mmol), 4-
pyrrolidinopyridine (197 mg, 1.33 mmol), and N,N-
dicyclohexylcarbodiimide (2.75 g, 13.33 mmol) in CH2Cl2
(50 mL) was stirred at r.t. for 12 h. The obtained
dicyclohexylurea was filtered off and washed with CH2Cl2
(2 × 25 mL). The filtrate was evaporated to dryness and the
residue recrystallised in from EtOH to provide the 2¢,6¢-
diaroyloxyacetophenones 3a–c (3a, 83%; 3b, 78%; 3c,
80%).
A mixture of the 2¢,4¢,6¢-trihydroxyacetophenone (2b, 0.86
g, 5.11 mmol), the appropriate benzoic acid (16.88 mmol),
4-pyrrolidinopyridine (250 mg, 1.69 mmol), and N,N-
dicyclohexylcarbodiimide (3.48 g, 16.87 mmol) in CH2Cl2
(100 mL) was stirred at r.t. for 20 h. The obtained
dicyclohexylurea was filtered off and washed with CH2Cl2
(2 × 30 mL). The filtrate was evaporated to dryness and the
residue recrystallised in from EtOH to provide the 2¢,4¢,6¢-
triaroyloxyacetophenones 4a–c (4a, 80%; 4b, 85%; 4c,
79%).
(16) Optimised Experimental Procedure
BBr3 (1.5 mol per benzyloxy group) was added to a solution
of the appropriate 3-aroyl-5-hydroxyflavone 5c and 6c
(0.3 mmol) in anhyd CH2Cl2 (25 mL) at low temperature
(–70 °C). After the addition was complete, the cooling
system was removed and the reaction mixture was stirred at
r.t. for 24 h. Then, H2O (50 mL) was added and the resulting
reaction mixture was stirred at r.t. for 2–3 h. The obtained
solid was filtered off and washed several times with H2O and
CH2Cl2; the expected 3-aroylflavones 7a,b were obtained in
good yields (7a, 62%; 7b, 58%).
(10) Physical Data of 2¢,4¢,6¢-Tribenzoyloxyacetophenone (4a)
1H NMR (300.13 MHz, CDCl3): d = 2.51 (s, 3 H, 2-CH3),
7.25 (s, 2 H, H-3¢,5¢), 7.52 (dd, 6 H, J = 7.6, 6.4 Hz, H-3,5 of
2¢,4¢,6¢-OCOC6H5), 7.66 (t, 3 H, J = 7.6 Hz, H-4 of 2¢,4¢,6¢-
OCOC6H5), 8.15–8.20 (m, 6 H, H-2,6 of 2¢,4¢,6¢-OCOC6H5)
ppm. 13C NMR (75.47 MHz, CDCl3): d = 31.4 (2-CH3),
114.6 (C-3¢,5¢), 125.8 (C-1¢), 128.4 (C-1 of 2¢,6¢-OCOC6H5),
128.6 (C-1 of 4¢-OCOC6H5), 128.7 (C-3,5 of 4¢-OCOC6H5),
128.8 (C-3,5 of 2¢,6¢-OCOC6H5), 130.25 (C-2,6 of 4¢-
OCOC6H5), 130.31 (C-2,6 of 2¢,6¢-OCOC6H5), 134.0 (C-4 of
4¢-OCOC6H5), 134.2 (C-4 of 2¢,6¢-OCOC6H5), 148.5 (C-
2¢,6¢), 152.0 (C-4¢), 164.1 (C=O of 4¢-OCOC6H5), 164.2
(C=O of 2¢,6¢-OCOC6H5), 197.5 (C-1) ppm. MS (ES+): m/z
(%) = 503 (100) [M + Na]+.
Physical Data of 3-(3,4-Dihydroxybenzoyl)-3¢,4¢,5,7-
tetrahydroxyflavone (7b)
1H NMR (300.13 MHz, DMSO-d6): d = 6.25 (d, 1 H, J = 1.9
Hz, H-6), 6.48 (d, 1 H, J = 1.9 Hz, H-8), 6.73 (d, 1 H, J = 8.4
Hz, H-5¢), 6.74 (d, 1 H, J = 8.2 Hz, H-5¢¢), 6.94 (dd, 1 H,
J = 8.4, 2.2 Hz, H-6¢), 7.06 (d, 1 H, J = 2.2 Hz, H-2¢), 7.24
(dd, 1 H, J = 8.2, 2.0 Hz, H-6¢¢), 7.29 (d, 1 H, J = 2.0 Hz, H-
2¢¢), 9.42, 9.86, and 10.06 (3 s, 4 H, 3¢,4¢,3¢¢,4¢¢-OH), 11.05
(s, 1 H, 7-OH), 12.48 (s, 1 H, 5-OH) ppm. 13C NMR (75.47
MHz, DMSO-d6): d = 94.0 (C-8), 99.1 (C-6), 103.0 (C-10),
115.4 (C-2¢,2¢¢), 115.7 (C-5¢ and C-5¢¢), 118.7 (C-3), 120.7
(C-1¢), 121.9 (C-6¢), 123.2 (C-6¢¢), 128.8 (C-1¢¢), 145.4 (C-3¢
and C-3¢¢), 149.2 (C-4¢), 151.7 (C-4¢¢), 157.3 (C-9), 161.3
(C-2), 161.5 (C-5), 164.7 (C-7), 179.9 (C-4), 190.7 (C=O)
ppm. MS (ES+): m/z (%) = 445 (63) [M + Na]+.
(11) Physical Data of 3¢,4¢-Dibenzyloxy-5-hydroxyflavone
(5d)
1H NMR (300.13 MHz, CDCl3): d = 5.25 and 5.26 (2 s, 2 × 2
H, 3¢,4¢-OCH2C6H5), 6.57 (s, 1 H, H-3), 6.80 (dd, 1 H,
J = 8.3, 0.7 Hz, H-6), 6.94 (dd, 1 H, J = 8.3, 0.7 Hz, H-8),
7.02 (d, 1 H, J = 8.5 Hz, H-5¢), 7.31–7.44 (m, 6 H, H-3,4,5
of 3¢,4¢-OCH2C6H5), 7.45 (br s, 1 H, H-2¢), 7.45–7.51 (m, 5
H, H-6¢ and H-2,6 of 3¢,4¢-OCH2C6H5), 7.52 (t, 1 H, J = 8.3
Hz, H-7), 12.64 (s, 1 H, 5-OH) ppm. 13C NMR (75.47 MHz,
CDCl3): d = 70.9 (3¢-OCH2C6H5), 71.5 (4¢-OCH2C6H5),
104.8 (C-3), 106.9 (C-8), 110.7 (C-10), 111.3 (C-6), 112. 8
(C-2¢), 114.0 (C-5¢), 120.7 (C-6¢), 123.9 (C-1¢), 127.1 and
127.4 (C-2,6 of 3¢,4¢-OCH2C6H5), 128.11 and 128.13 (C-4 of
3¢,4¢-OCH2C6H5), 128.7 (C-3,5 of 3¢,4¢-OCH2C6H5), 135.2
(C-7), 136.3 and 136.6 (C-1 of 3¢,4¢-OCH2C6H5), 148.8 (C-
(17) Physical Data of 3¢,4¢-Dibenzyloxy-3-(3,4-
dibenzyloxybenzoyl)-5-hydroxyflavone (5c)
1H NMR (300.13 MHz, CDCl3): d = 4.89 (s, 2 H, 3¢-
OCH2C6H5), 5.16 (s, 2 H, 4¢-OCH2C6H5), 5.14 (s, 2 H, 3¢¢-
OCH2C6H5), 5.21 (s, 2 H, 4¢¢-OCH2C6H5), 6.83 (dd, 1 H,
J = 8.4, 0.7 Hz, H-6), 6.85 (d, 1 H, J = 8.6 Hz, H-5¢), 6.88 (d,
1 H, J = 8.5 Hz, H-5¢¢), 6.96 (dd, 1 H, J = 8.4, 0.7 Hz, H-8),
7.16 (d, 1 H, J = 2.2 Hz, H-2¢), 7.22 (dd, 1 H, J = 8.6, 2.2 Hz,
H-6¢), 7.23–7.43 (m, 20 H, H-2,3,4,5,6 of 3¢,4¢,3¢¢,4¢¢-
OCH2C6H5), 7.47 (dd, 1 H, J = 8.5, 2.0 Hz, H-6¢¢), 7.59 (t, 1
H, J = 8.4 Hz, H-7), 7.59 (d, 1 H, J = 2.0 Hz, H-2¢¢), 12.23
(s, 1 H, 5-OH) ppm. 13C NMR (75.47 MHz, CDCl3): d =
Synlett 2007, No. 12, 1897–1900 © Thieme Stuttgart · New York